Gundaya, Cresencia .

HRN: 27-62-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/10/2025
08/17/2025
IV
4.5
Q8
Sepsis Probably Sec To Complicated UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: